Digitek (generic: digoxin)
On April 25, 2008, Actavis Totowa recalled all lots nationwide of all oral use strengths of Digitek®. Digitek® is used to treat heart failure and abnormal heart rhythms. This total recall is due to the possibility that tablets may contain twice the approved level of active ingredient. These double strength tablets pose a risk of digitalis toxicity. All digitalis compounds, which included Digitek, have a well know major side effect, namely, cardiac arrhythmia, especially in patients with atrial tachycardias (A rapid rhythm of the heart in which the origin of the electrical signal is in the atria or blood collection chamber of the heart.) and atrioventricular block (A block of the heart’s electrical system where the conduction between the atria and ventricles of the heart is affected.).
Digitalis toxicity is the result of the body accumulating more digitalis than it can tolerate at that time. That can be caused by high levels of digitalis in the body, or it can be caused by “normal” levels but decreased tolerance by the body. If kidney function is impaired or reduced, digoxin levels in the blood increase because digoxin is eliminated by the kidneys. Lean, elderly patients are also more susceptible to digitalis toxicity because they often have reduced renal function and their reduced muscle mass increases plasma digoxin levels at a given dose because the muscle acts as a large binding reservoir for digitalis.
Do I Have a Digitek / Digoxin Recall Lawsuit?
If you or a loved one has suddenly experienced these symptoms after taking Digitek, contact Bailey & Galyen to discuss your legal rights. You may use the form below or call toll free 24 hrs/day (866) 879-3040 for a free confidential case evaluation.
Secure 128-bit SSL Encrypted Email Communication
